Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10476942

Download in:

View as

General Info

PMID
10476942